Demetra is the world leading independent player in the bone cement and biomaterials space

Demetra, the world independent leader in the bone cement and biomaterials space, combines the two leading independent players in the field, namely Tecres S.p.A. (Italy) and aap Biomaterials GmbH (Germany). The group employs 140 people and has operations in Germany and Italy. Through its know-how and R&D capacities, Demetra is positioned as one of the most innovative players in the orthopedic sceptic treatment solutions field. Keensight Capital provided an equity investment in Demetra Holding to finance the acquisition of aap Biomaterials (Germany) and to combine it with Tecres (Italy).

Headquarter

ITALY/GERMANY

Investment Year

2016

Status

CURRENT